• Cryptocurrencies
  • Prediction Markets
  • News
  • Agentic Trading
  • Blog
  • Leagues

Search Cryptocurrencies

Trending Cryptocurrencies

CoinRithm

Company

Legal Entity
Bees-x Limited
Company Number
13308136
Incorporated In
England and Wales
Registered Office
Monmouth House, High Street, Watford, England, WD17 1LN

CoinRithm is an information and research service operated by Bees-x Limited. It is not authorised by the Financial Conduct Authority (FCA) to carry on regulated activities, and nothing on this site is financial advice.

Explore

CryptocurrenciesPrediction MarketsNewsBlogAgent ArenaLeagues

Features

DashboardMock TradeAgentic TradingPortfolioWatchlistSettings

Company

About UsMethodologyTerms of UsePrivacy PolicyCookie PolicyDisclaimer

Support

Contact SupportFAQDeveloper kitMCP docs

Socials

X (Twitter)FacebookLinkedInTelegramInstagramTikTokYouTube
© 2026 CoinRithm. All rights reserved.
Get it on Google PlayDownload on the App Store
  • Home
  • MarketsPrediction Markets
  • News
  • Dashboard
  1. Prediction Markets
  2. Health & Medicine
  3. What will the phase 3 clinical trial results report for vaccine efficacy (%) of the R21 malaria vaccine at 48 months?
Manifold Markets

What will the phase 3 clinical trial results report for vaccine efficacy (%) of the R21 malaria vaccine at 48 months?

Health & MedicineOne-Off2mo
Manifold MarketsManifold MarketsNo KYC
Current community forecast
Manifold Markets
20-29% 9.4%
Leader of 7 outcomes
Forecasters

11

Question type

multiple choice

Methodology

Play-money forecasting platform

Source type

Forecast

Market data

Updated 2 days ago

Stale
Mar 15, 24, 9:29 PMSep 2, 26, 6:59 AM

Trends

Outcome24hChance

Selected outcome

20-29%9%

Rules

The 12 month phase 3 data indicates 75% vaccine efficacy of R21 in annual malaria sites in children at 12 months after the first dose was delivered.

Manifold Markets
  • Phase 2b data at a 42 month timepoint showed 71% efficacy after four total doses (Abstract here, #6949).
  • Resolves upon publication of peer-reviewed data from the R21 team at Oxford (expected to be before September 1st, 2026).
  • Vaccine efficacy is defined as the primary endpoint for time to clinical malaria in seasonal sites, as defined in the paper linked above.
  • 1Day Sooner has an R21 Status Report available here that may be useful.
  • More malaria-related questions can be found on our Manifold account here.

Related Markets

Hantavirus pandemic in 2026?

Hantavirus pandemic in 2026?

$170.1K
Yes: 5%PolymarketPOLYMARKET
New pandemic in 2026?

New pandemic in 2026?

$19.2K
Yes: 10%PolymarketPOLYMARKET
Ebola pandemic in 2026?

Ebola pandemic in 2026?

$10.1K
Yes: 8%PolymarketPOLYMARKET
Manifold Markets

How many movies will gross >$1 billion in 2026?

$1.5K
0-3: 5.7%Manifold MarketsMANIFOLD MARKETS
Manifold Markets

Which disease will be eradicated next in humans?

$533.9
Polio: 26.7%Manifold MarketsMANIFOLD MARKETS
When, where or how will Trump die?

When, where or how will Trump die?

$159.1
2025: 0%Manifold MarketsMANIFOLD MARKETS

Active in these topics

BitcoinBTC$62,722.26+1.67%EthereumETH$1,654.92+0.92%SolanaSOL$65.02+0.78%DogecoinDOGE$0.0848+0.72%XRPXRP$1.12-0.19%BNBBNB$597.92+1.56%

Related News

Chainalysis reveals $100 million peptide market built on cryptoCrypto NewsGray peptide vendors embrace stablecoins as safety fears deepenCrypto NewsOpenAI Expands GPT-Rosalind Access with Rosalind BiodefenseBlockchain.NewsOpenAI Expands GPT-Rosalind Capabilities for Life SciencesBlockchain.NewsBrian Armstrong’s NewLimit Raises $435M for Human TrialsCrypto News

Rules

The 12 month phase 3 data indicates 75% vaccine efficacy of R21 in annual malaria sites in children at 12 months after the first dose was delivered.

Manifold Markets
  • Phase 2b data at a 42 month timepoint showed 71% efficacy after four total doses (Abstract here, #6949).
  • Resolves upon publication of peer-reviewed data from the R21 team at Oxford (expected to be before September 1st, 2026).
  • Vaccine efficacy is defined as the primary endpoint for time to clinical malaria in seasonal sites, as defined in the paper linked above.
  • 1Day Sooner has an R21 Status Report available here that may be useful.
  • More malaria-related questions can be found on our Manifold account here.